Literature DB >> 4323415

Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis.

B Zbar, T Tanaka.   

Abstract

Injection of living Mycobacterium bovis (strain BCG) into established intradermal tumors caused tumor regression and prevented the development of metastases.

Entities:  

Mesh:

Year:  1971        PMID: 4323415     DOI: 10.1126/science.172.3980.271

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  48 in total

Review 1.  Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties.

Authors:  E Lederer; A Adam; R Ciorbaru; J F Petit; J Wietzerbin
Journal:  Mol Cell Biochem       Date:  1975-05-30       Impact factor: 3.396

Review 2.  Immune therapies in non-muscle invasive bladder cancer.

Authors:  Philip L Ho; Stephen B Williams; Ashish M Kamat
Journal:  Curr Treat Options Oncol       Date:  2015-02

3.  Immunogenicity of viable tumor cells. A comparison of xenogenized tumor cells and BCG-tumor cell mixtures.

Authors:  Y Suzuki; K Suzuki; M Hosokawa; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 4.  Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Authors:  Lisa M Coussens; Laurence Zitvogel; A Karolina Palucka
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

5.  Inhibitory effect of vitamin D-binding protein-derived macrophage activating factor on DMBA-induced hamster cheek pouch carcinogenesis and its derived carcinoma cell line.

Authors:  Yukiyo Toyohara; Susumu Hashitani; Hiromitsu Kishimoto; Kazuma Noguchi; Nobuto Yamamoto; Masahiro Urade
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

6.  A study of reactions to Corynebacterium parvum (C. parvum) in the brain and dermis of the rat.

Authors:  H M Cravioto; G M Hochwald; J Ransohoff
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

7.  Effect of systemic BCG infection in syrian golden hamsters.

Authors:  B S Zwilling; G W Davis
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

8.  Participation of serum proteins in the inflammation-primed activation of macrophages.

Authors:  N Yamamoto; N P Willett; D D Lindsay
Journal:  Inflammation       Date:  1994-06       Impact factor: 4.092

9.  In vivo and in vitro activation of macrophages with a cyanine photosensitizing dye, platonin.

Authors:  Y Nakagawa; S Homma; I Yamamoto; M Banno; H Nakazato; H Imanaga; N Yamamoto
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

10.  Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells.

Authors:  N Yamamoto; S Homma; J G Haddad; M A Kowalski
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.